EKF Diagnostics (LON:EKF) Reaches New 12-Month Low – What’s Next?

EKF Diagnostics Holdings plc (LON:EKFGet Free Report) shares reached a new 52-week low on Wednesday . The company traded as low as GBX 22.60 ($0.29) and last traded at GBX 22.60 ($0.29), with a volume of 1199935 shares trading hands. The stock had previously closed at GBX 23 ($0.29).

EKF Diagnostics Trading Down 1.7 %

The company has a quick ratio of 1.77, a current ratio of 4.60 and a debt-to-equity ratio of 0.34. The firm has a market capitalization of £100.45 million, a P/E ratio of 21.03 and a beta of 0.57. The stock has a fifty day simple moving average of GBX 25.68 and a 200 day simple moving average of GBX 26.87.

About EKF Diagnostics

(Get Free Report)

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

See Also

Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.